Contineum Therapeutics, Inc.: Form 8-K/A, filed Aug 14, 2024
Filed with the SEC on Aug 14, 2024 and accepted by EDGAR at Aug 14, 2024, 12:19 ET.
Items reported
- Item 2.02 Results of operations
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001437749-24-026664. Last ingested by Listed: Nov 6, 2026, 12:53 ET. Listed shows no prices and gives no investment advice.